Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992471 · ClinicalTrials.gov registry record
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 197
- Enrollment target
NCT01992471: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01992471 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 197 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01992471 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what kinds of information people would like to receive from a new kind of genetic testing, and how they respond to this new kind of testing.
Primary Outcome
Proportions of subjects declaring a pre-test preference to receive 1) all available information, 2) all information related to breast cancer predisposition (whether or not clinical utility is established), 3) all information of established clinical utility (whether related to breast cancer risk or not), 4) only a subset of high-penetrance information (masking certain results), 5) no information.
Interventions
- OTHER Blood draw
- BEHAVIORAL Pre-test Assessment
- BEHAVIORAL Pre test Counseling
- BEHAVIORAL Post-test counseling, and post-test assessment
- BEHAVIORAL Follow-up assessments (6 and 12 months)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-12-01 |
What the finished NCT01992471 record still lists
NCT01992471 is an observational study that tracks outcomes without assigning an intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which Blood draw is the first listed.
NCT01992471 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01992471 about?
NCT01992471 is a clinical study titled "Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing". The purpose of this study is to find out what kinds of information people would like to receive from a new kind of genetic testing, and how they respond to this new kind of testing.
What is the current status of trial NCT01992471?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2013-11. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT01992471?
The interventions under investigation include: Blood draw (OTHER), Pre-test Assessment (BEHAVIORAL), Pre test Counseling (BEHAVIORAL), Post-test counseling, and post-test assessment (BEHAVIORAL), Follow-up assessments (6 and 12 months) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01992471?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia